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Objective Children are sedated before undergoing diagnostic imaging tests in emergency medi-
cine or pediatric sedation anesthesia units. The aim of this study was to identify variables poten-
tially affecting the dose of ketamine required for induction of sedation in pediatric patients un-
dergoing diagnostic imaging.
Methods This retrospective study included children aged 0 to 18 years who underwent sedation 
with ketamine for computed tomography or magnetic resonance imaging in the pediatric seda-
tion anesthesia unit of a tertiary medical center between January 2011 and August 2016. The 
children’s hemodynamic status and depth of sedation were monitored during the examination. 
We recorded data on demographics, categories of imaging tests, ketamine doses administered, 
adverse events, respiratory interventions, and duration of sedation. Data for patients who expe-
rienced adverse events were excluded.
Results Sixty-six patients were included in the final analysis. Univariate linear regression analysis 
revealed that patient age, height, and body surface area (BSA) affected the sedative dose of ket-
amine administered. These three variables showed multicollinearity in multivariate linear regres-
sion analysis and were analyzed in three separate models. The model with the highest adjusted 
R-squared value suggested the following equation for determination of the dose of ketamine re-
quired to induce sedation: ketamine dose (mg)=-1.62+0.7×age (months)+36.36×BSA (m2).
Conclusion Variables such as age and BSA should be considered when estimating the dose of 
ketamine required for induction of sedation in pediatric patients. 
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What is already known
Ketamine is an anesthetic agent widely used for pediatric sedation. Currently, 
the initial dose of ketamine is based on the patient’s weight, ranging from 1 to 
2 mg/kg intravenously.
What is new in the current study
This study identified variables that can affect the induction dose of ketamine 
required for sedation in pediatric patients undergoing diagnostic tests and de-
rived a formula for calculating the dose using weight, age, and body surface 
area. 
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INTRODUCTION
Examinations using diagnostic imaging modalities such as com-
puted tomography and magnetic resonance imaging are becom-
ing increasingly common in pediatric sedation and anesthesia 
units. Therefore, it is becoming important to ensure adequate se-
dation of patients undergoing such examinations.1
 If the level of sedation is inadequate, a child may move during 
the imaging procedure, which interferes with the examination, 
whereas deep sedation may lead to complications, such as apnea 
and hemodynamic instability. Therefore, appropriate doses of an-
esthetic agents are essential for successful examination of chil-
dren undergoing diagnostic imaging tests.2,3
 Ketamine is an anesthetic agent that is widely used for pediat-
ric sedation. Currently, the initial dose of ketamine is based on 
the patient’s weight and is in the range of 1.0–2.0 mg/kg intrave-
nously, and a further dose is considered if the duration of exami-
nation is extended or if the patient is noticed to be about to wake 
up or shows movement. However, the optimal dose of ketamine 
can vary for a number of reasons, including the patient’s medical 
condition, the environment in the examination room, and the 
type of diagnostic test being performed. Furthermore, anthropo-
metric variables other than weight, such as age, height, and body 
surface area (BSA), could influence the optimal dose of ketamine. 
Therefore, a specific guideline for determining the optimal dose 
of ketamine could help to improve the success rate of diagnostic 
examinations and decreasing the risk of complications.4-6
 The aim of this study was to identify variables that could af-
fect the dose of ketamine required for induction of sedation in 
pediatric patients undergoing diagnostic tests and to devise a 
formula for calculating the optimal dose using those variables.
METHODS
This study was approved by the Institutional Ethical Committee 
(IRB number: 4-2016-0733). Informed consent was waived due 
to the retrospective nature of the study. This retrospective obser-
vational study included children aged 0 to 18 years who were se-
dated in the pediatric sedation and anesthesia unit at our tertiary 
medical center from January 2011 to August 2016. The medical 
records of patients who received ketamine for sedation during an 
imaging procedure were evaluated. 
 Pediatric inpatients and outpatients who were referred for di-
agnostic imaging (computed tomography or magnetic resonance 
imaging) under sedation were included in the study. An anesthe-
siologist and a nurse monitored each patient’s hemodynamic sta-
tus and depth of sedation during the examination. Monitoring 
devices for pulse oximetry, noninvasive measurement of blood 
pressure, electrocardiography, and capnography were connected 
to the child before the examination. Glycopyrrolate 0.004 mg/kg 
was injected intravenously and ketamine 1 mg/kg was adminis-
tered for intravenous sedation. Loss of consciousness was judged 
by disappearance of the eyelash reflex and no resistance to fitting 
of the mask. If the patient remained conscious, an additional 
1-mg/kg dose of ketamine was administered. The sedation level 
was maintained at 5 to 6 points on the Modified Ramsay Seda-
tion Scale. When the imaging study was finished, the child was 
taken to the recovery room. The child was discharged from the 
recovery room if hemodynamic values were maintained within 
±20% of the pre-sedation values, the modified Aldrete post an-
esthesia recovery score remained over 9 points, and if the child 
was fully awake.
 We recorded the patient characteristics, including weight, age, 
height, and BSA. The type of imaging test, doses of sedatives ad-
ministered until unconsciousness, adverse events, respiratory in-
terventions for sedation, and duration of sedation were also re-
corded. Data for patients who experienced an adverse event, such 
as desaturation or hemodynamic instability, were excluded from 
the analysis. BSA was defined as follows: 0.016667×0.5×body 
weight (kg)×0.5×height (cm).
Study outcomes and data analyses
The primary aim of the study was to identify the factors most 
closely related to the dose of ketamine required for induction of 
sedation. The relationships of sex, age, weight, height, and BSA 
with the dose of ketamine required for induction of sedation 
were analyzed using linear regression. The regression equation 
was then used in multivariate analysis. The variance inflation fac-
tor was checked for multiple collinearity before performing the 
multivariate linear regression. Multicollinearity was determined 
to be present when the variance inflation factor was >10. If 
multiple collinearity exists between independent variables, they 
cannot be analyzed in a single model; therefore, the study vari-
ables were analyzed using three different models. Each model 
was inspected visually for linearity, heteroscedasticity, and nor-
mality of the residuals. All analyses were performed using SAS 
ver. 9.4 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Two hundred and ninety-six of 1,200 pediatric patients who re-
ceived ketamine for sedation during diagnostic imaging had 
complete medical records available for analysis. After exclusion 
of the records for 230 patients who either did not have accurate 
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information available for height and weight or experienced ad-
verse events, data for 66 patients were available for inclusion in 
the analysis. The demographic characteristics of the patients are 
shown in Table 1. The average dose of ketamine required for in-
duction of sedation was 2.29 mg/kg. In the univariate linear re-
gression analyses, age, height, body weight, and BSA were identi-
fied to be factors affecting the dose required (Table 2 and Fig. 1). 
 The variance inflation factor was checked for multiple collin-
earity before performing the multivariate linear regression. The 
independent variables of height, weight, and BSA showed multi-
ple collinearity, so it was not possible to analyze them in the 
Table 1. Patient demographics and clinical data   
Characteristics Value
Sex (male/female) 41/25
Median age (mo)      1.45 (0.4–3.3)
Height (cm) 54.6±10.7
Body weight (kg) 4.8±2.6
Type of imaging procedure
   CT
   MRI
   CT+MRI 
  
24 (36.3)
42 (63.7)
0
Sedation time (min) 21.7±12.1
Value are presented as number, median (interquartile range), mean±standard 
deviation, or number (%).   
CT, computed tomography; MRI, magnetic resonance imaging.  
Fig. 1. Scatter plot about linear correlation. (A-D) Correlation between various characteristic and induction dose of ketamine for sedation. This shows a 
tendency toward increasing slope line with increasing (A) age, (B) height, (C) body weight, and (D) body surface area (BSA). 
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Table 2. Univariate regression analysis to identify independent factors 
affecting induction dose of ketamine for sedation (n=66) 
Variable β (SE) P-value
Sex -2.000 (2.257) 0.379
Age (mo) 1.336 (0.128) <0.001
Height (cm) 0.646 (0.066) <0.001
Body weight (kg) 2.657 (0.272) <0.001
BSA (m²) 71.409 (6.991) <0.001
SE, standard error; BSA, body surface area.
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same model at the same time (Table 3). Therefore, the relation-
ship between patient age and each variable was analyzed using 
three different models (Table 4). Model 3, in which age and BSA 
were analyzed together, had the highest adjusted R-squared val-
ue at 0.658; therefore, we chose model 3, which suggested the 
following equation for determining the dose of ketamine required 
for induction of sedation taking into account age and BSA: 
Dose of ketamine to induce sedation (mg) =-1.62+0.7 ×age 
(mo)+36.36×BSA (m2)
 Additionally, to verify a normal distribution and iso-dispersion 
of residuals, a residual analysis was performed using studentized 
residuals. As shown in Fig. 2, the dots appear to be randomly dis-
tributed with no particular tendency centering around zero. The 
trend is centered around zero but the variance around zero is also 
scattered uniformly and randomly. To evaluate the skewness of 
the distribution, we constructed a probability-probability plot (Fig. 
3). The points on this plot form a nearly linear pattern, indicating 
that the normal distribution is a good model for this dataset.
DISCUSSION
In this study, we reviewed the medical records of children who 
were successfully sedated with ketamine and performed a regres-
sion analysis of the relationship between the dose of ketamine 
and several anthropometric characteristics. The regression analy-
sis showed that the dose of ketamine required for induction of 
sedation increased with patient age, height, weight, and BSA. The 
multiple regression analysis indicated that the appropriate dose 
of ketamine for induction of sedation in children can be calculat-
ed accurately using the following formula:
-1.62+0.7×age (mo)+36.36×BSA (m2). 
 The optimal dose of ketamine required for sedation is also as-
sociated with other anthropometric characteristics, including age, 
height, and BSA. According to the current guideline, the required 
Table 4. Multivariate linear regression analysis of age and other vari-
ables including height, body weight, and BSA   
β (standard error) P-value
Model 1 Adjusted R-squared value=0.651
   Intercept -7.982 (5.912) 0.182
   Age (mo) 0.812 (0.246) 0.002
   Height (cm) 0.299 (0.121) 0.016
Model 2 Adjusted R-squared value=0.651
   Intercept 2.494 (1.796) 0.170
   Age (mo) 0.825 (0.241) 0.001
   Body weight (kg) 1.213 (0.492) 0.016
Model 3 Adjusted R-squared value=0.658
   Intercept -1.620 (3.062) 0.599
   Age (mo) 0.749 (0.247) 0.004
   BSA (m2) 36.359 (13.294) 0.008
BSA, body surface area. 
Table 3. Calculation of variance inflation factor to check for multicol-
linearity 
Variable Variance inflation factor
Age 4.581
Height 50.954
Body weight 442.738
Body surface area (m²) 713.506
Multi-collinearity exists if the variance inflation factor is >10. 
Fig. 2. Scatter plot. Residual plot. Dependent variable: induction dose of 
ketamine for pediatric sedation. The dots appear randomly distributed 
with no particular tendency centering around zero.
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Fig. 3. P-P plot of regression standardized residual. Probability plot. De-
pendent variable: induction dose of ketamine for pediatric sedation. The 
points on this plot form a nearly linear pattern, which indicates that the 
normal distribution is a good model for this dataset.
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dose of ketamine is determined on the basis of weight; an intra-
venous loading dose of 1–2 mg/kg is used in children.7,8 Linear 
regression analysis in this study identified age, BSA, and height to 
be significant factors for determining the dose. The most explica-
ble regression equation was used to devise a formula that could 
determine the dosage of ketamine required for pediatric sedation. 
If the dosage is determined considering only one factor, the dose 
range may be too wide. Furthermore, children may be susceptible 
to small dose changes, which could make it difficult to identify 
the appropriate dose. Physicians who are inexperienced in pediat-
ric sedation may find it particularly difficult to select the appro-
priate dose. Consideration of other patient factors, including 
weight, can increase the accuracy and success rate of sedation. 
 In this study, we found that it was useful to include BSA in the 
formula used to estimate the dosage of ketamine required for pe-
diatric sedation. In children, many physical factors, including 
weight, can affect the pharmacokinetics and pharmacodynamics 
of an anesthetic agent. Therefore, these factors need to be consid-
ered in combination, rather than considering weight in isola-
tion.9-12 An earlier study that calculated the dose of propofol re-
quired for sedation also considered weight in addition to age.13 
However, for ketamine, only weight has been considered until now 
in research concerning the optimal dose required for sedation.
 We did not include patient age as a variable in the formula. 
Body composition, function, and degree of protein binding vary 
according to age, so the response to administration of the same 
amount of medication is age-dependent. Therefore, the optimal 
dose should also vary according to age. Calculating the dose con-
sidering age and weight together rather than weight alone will 
help to establish a guideline that takes the clinical response into 
account. However, it is not easy to reflect age in an objective 
manner. The existing guideline suggests that children need a 
greater dose per kilogram than adults, and there is no formula for 
calculating the dose by substituting a specific age or other 
factor(s). Unlike in the existing guideline, the range of selectable 
doses can be reduced by reflecting age as a numeric item, as in 
the equation presented here.
 Ketamine is a derivative of cyclohexamine that produces seda-
tion and analgesia by separating the cerebral cortex from the 
limbic system of the brain while preserving the body’s reflexes, 
including the vomiting and laryngeal reflexes. In the existing 
guideline, the suggested induction dose is determined on the ba-
sis of weight alone. However, there is wide patient-to-patient 
variability in the response to ketamine. Therefore, it is not appro-
priate to consider only weight when determining the optimal in-
duction dose for sedation. This is the first study to show that the 
optimal ketamine dose can be calculated using other factors, in-
cluding body weight. However, even if the guideline presented in 
this study is applied, the possibility of an adverse event due to 
ketamine cannot be ruled out, so precautionary measures are still 
necessary during sedation using ketamine.
 This study has some limitations. First, the optimal dosage of a 
drug should be determined with a focus on preventing side ef-
fects by minimizing overdose; the dose of ketamine used in this 
study (1 mg/kg) may be appropriate for some patients, but may 
be an overdose in some patients despite achieving the desired se-
dation level. Second, the proposed formula could be cumbersome 
to use when administering ketamine in routine practice because 
it requires additional calculation of BSA. Third, the patients had 
various underlying medical conditions. Fourth, the study relied on 
accurate documentation of medical records, which may have 
been inadequate. However, this shortcoming may be offset by the 
use of objective measurements of sedation depth, such as loss of 
the eyelash reflex and acceptance of the face mask, during the 
study period. Fifth, various anesthesiologists performed the mea-
surements. Judgment of patient movement and level of sedation 
may vary between operators, and the extent to which this varia-
tion may have influenced the findings of the study is unknown.
 In summary, the anthropometric variables of age, height, and 
BSA should be taken into account when estimating the dose of 
ketamine required for induction of anesthesia in pediatric pa-
tients. The equation proposed here may be helpful for determin-
ing the dosages required for pediatric sedation. However, further 
clinical investigations are required to validate its effectiveness.
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